Abstract
摘要
相似文献
1
Chlorambucil.
IARC Monogr Eval Carcinog Risk Chem Man. 1975;9:125-34.
2
Chlorambucil.
IARC Monogr Eval Carcinog Risk Chem Hum. 1981 May;26:115-36.
3
Tris(2-methyl-1-aziridinyl)phosphine oxide.
IARC Monogr Eval Carcinog Risk Chem Man. 1975;9:107-13.
4
Trichlorotriethylamine hydrochloride.
IARC Monogr Eval Carcinog Risk Chem Man. 1975;9:229-34.
5
Reserpine.
IARC Monogr Eval Carcinog Risk Chem Man. 1976;10:217-29.
6
Serum displacing agents in cancer chemotherapy.
Cancer Treat Rep. 1977 Oct;61(7):1407-10.
7
Tris (1-aziridinyl)phosphine sulphide.
IARC Monogr Eval Carcinog Risk Chem Man. 1975;9:85-94.
8
Melphalan, medphalan & merphalan.
IARC Monogr Eval Carcinog Risk Chem Man. 1975;9:167-80.
9
Azaserine.
IARC Monogr Eval Carcinog Risk Chem Man. 1976;10:73-7.
10
Effects of chlorambucil (NSC-3088) in 374 patients with advanced cancer. Eastern Clinical Drug Evualuation Program.
Cancer Chemother Rep. 1968 Oct;52(6):661-6.
Zotero 插件